Document is current
Any future updates will be listed below
-
Authors
Caratelli, Sara
De Paolis, Francesca
Silvestris, Domenico Alessandro
Baldari, Silvia
Salvatori, Illari
Tullo, Apollonia
Lanzilli, Giulia
Gurtner, Aymone
Ferri, Alberto
Valle, Cristiana
Padovani, Simona
Cesarini, Valeriana
Sconocchia, Tommaso
Cifaldi, Loredana
Arriga, Roberto
Spagnoli, Giulio Cesare
Ferrone, Soldano
Venditti, Adriano
Rossi, Piero
Pesole, Graziano
Toietta, Gabriele
Sconocchia, Giuseppe
-
Funding
Funding for this research was provided by:
European Union, European Fund for Regional Development (TITAN 2021- ARS01_00906, TITAN 2021- ARS01_00906)
Italian Association for Cancer Research (AIRC) Foundation (Investigator Grants 2020-24440)
- License Information
-
More Information
Article History
Received: 30 October 2024
Accepted: 19 January 2025
First Online: 17 February 2025
Declarations
:
: Patent no. 102014902258369 (Ex TO2014A000361) Innate Chimeric Receptors for Immunotherapy awarded on July 12, 2019 to G Sconocchia and S Caratelli; US Patent Application, No: US 2024/0082400A1. CD64 chimeric receptor and uses thereof, Pub. Data on Mar.14,2024 to SF, GS, SC.
